BR0309032A - Método para tratar sintomas vasomotores, a menopausa, deficiências hormonais em um paciente, e para tratar um paciente que sofre de sintomas vasomotores - Google Patents
Método para tratar sintomas vasomotores, a menopausa, deficiências hormonais em um paciente, e para tratar um paciente que sofre de sintomas vasomotoresInfo
- Publication number
- BR0309032A BR0309032A BR0309032-9A BR0309032A BR0309032A BR 0309032 A BR0309032 A BR 0309032A BR 0309032 A BR0309032 A BR 0309032A BR 0309032 A BR0309032 A BR 0309032A
- Authority
- BR
- Brazil
- Prior art keywords
- vasomotor symptoms
- treat
- patient
- menopause
- patient suffering
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
"MéTODO PARA TRATAR SINTOMAS VASOMOTORES, A MENOPAUSA, DEFICIêNCIAS HORMONAIS EM UM PACIENTE, E PARA TRATAR UM PACIENTE QUE SOFRE DE SINTOMAS VASOMOTORES". A presente invenção inclui métodos para tratar sintomas vasomotores através da administração de compostos estrogênicos. Os métodos apresentados podem incluir terapia de estrogênio de partida em uma dose alta e, depois diminuindo a dose assim que a terapia se mostrar eficaz.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36990502P | 2002-04-03 | 2002-04-03 | |
PCT/US2003/002873 WO2003084547A1 (en) | 2002-04-03 | 2003-01-31 | Step-down estrogen therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0309032A true BR0309032A (pt) | 2005-02-01 |
Family
ID=28792001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0309032-9A BR0309032A (pt) | 2002-04-03 | 2003-01-31 | Método para tratar sintomas vasomotores, a menopausa, deficiências hormonais em um paciente, e para tratar um paciente que sofre de sintomas vasomotores |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030216366A1 (pt) |
EP (1) | EP1494679A4 (pt) |
AU (1) | AU2003210759B2 (pt) |
BR (1) | BR0309032A (pt) |
CA (1) | CA2481310A1 (pt) |
MX (1) | MXPA04009671A (pt) |
WO (1) | WO2003084547A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU230759B1 (hu) * | 2001-12-05 | 2018-03-28 | Teva Women's Health, Inc. | Teherbeesés megakadályozására és menstruációs tünetek enyhítésére vagy kiküszöbölésére alkalmas orális készítmények |
US7345096B2 (en) * | 2002-10-15 | 2008-03-18 | Wyeth | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
EP1624848A4 (en) * | 2003-05-02 | 2009-02-25 | Duramed Pharmaceuticals Inc | METHOD FOR HORMONY TREATMENT WITH CONTRAZEPTVA SCHEMATES WITH EXTENDED CYCLE |
NZ585546A (en) * | 2003-07-16 | 2011-10-28 | Teva Womens Health Inc | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
US20060040904A1 (en) * | 2004-08-17 | 2006-02-23 | Ahmed Salah U | Vaginal cream compositions, kits thereof and methods of using thereof |
AR051931A1 (es) * | 2004-10-07 | 2007-02-21 | Duramed Pharmaceuticals Inc | Metodos de tratamiento hormonal que utilizan regimenes de ciclos extendidos con dosis ascendentes |
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
EP2289486A1 (en) * | 2005-12-27 | 2011-03-02 | Teva Women's Health, Inc. | Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
US20080021003A1 (en) * | 2006-06-13 | 2008-01-24 | Vladimir Hanes | Extended step-down estrogen regimen |
US8617597B2 (en) | 2006-07-06 | 2013-12-31 | Bayer Intellectual Property Gmbh | Pharmaceutical composition containing a tetrahydrofolic acid |
US9220692B2 (en) | 2010-05-05 | 2015-12-29 | Teva Women's Health, Inc. | Methods of reducing symptoms in subjects using single dosage forms with tapering release rates |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2271832A1 (en) * | 1974-05-22 | 1975-12-19 | Dynachim Sarl | Compsns. contg. sex hormones and their esters - for improving wt. gain in meat animals |
US4381298A (en) * | 1981-10-13 | 1983-04-26 | Coulson Patricia B | Oral male contraceptive composition |
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
US5043331A (en) * | 1989-06-15 | 1991-08-27 | Orion-Yhtyma Oy | Treatment of postmenopausal disorders |
ATE275957T1 (de) * | 1993-01-19 | 2004-10-15 | Endorech Inc | Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron |
US6262115B1 (en) * | 1995-05-22 | 2001-07-17 | Alza Coporation | Method for the management of incontinence |
US5861431A (en) * | 1995-06-07 | 1999-01-19 | Iotek, Inc. | Incontinence treatment |
US6139873A (en) * | 1996-07-10 | 2000-10-31 | Cedars-Sinai Medical Center | Combined pharmaceutical estrogen-androgen-progestin |
ZA979204B (en) * | 1996-10-16 | 1999-04-14 | American Home Prod | Use of 8,9-dehydroestrone in treating vasomotor symptoms |
EP1187618A1 (en) * | 1999-06-04 | 2002-03-20 | The General Hospital Corporation | Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use |
MXPA01012769A (es) * | 1999-06-11 | 2003-06-24 | Watson Pharmaceuticals Inc | Administracion de esteroides androgenicos no orales para mujeres. |
US20010034340A1 (en) * | 2000-03-20 | 2001-10-25 | American Home Products Corporation | Hormone replacement therapy |
-
2003
- 2003-01-31 CA CA002481310A patent/CA2481310A1/en not_active Abandoned
- 2003-01-31 EP EP03746025A patent/EP1494679A4/en not_active Withdrawn
- 2003-01-31 MX MXPA04009671A patent/MXPA04009671A/es unknown
- 2003-01-31 AU AU2003210759A patent/AU2003210759B2/en not_active Ceased
- 2003-01-31 US US10/356,242 patent/US20030216366A1/en not_active Abandoned
- 2003-01-31 WO PCT/US2003/002873 patent/WO2003084547A1/en not_active Application Discontinuation
- 2003-01-31 BR BR0309032-9A patent/BR0309032A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2481310A1 (en) | 2003-10-16 |
US20030216366A1 (en) | 2003-11-20 |
MXPA04009671A (es) | 2005-01-25 |
EP1494679A4 (en) | 2009-10-28 |
EP1494679A1 (en) | 2005-01-12 |
AU2003210759B2 (en) | 2007-01-25 |
AU2003210759A1 (en) | 2003-10-20 |
WO2003084547A1 (en) | 2003-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0314308A (pt) | Composto, composição farmacêutica, métodos para bloquear uma combinação de mu, kappa, delta ou receptor (heterodìmero) dos mesmos em mamìferos, para tratar ou prevenir obesidade e doenças relacionadas, para suprimir o apetite em um paciente em necessidade deste, e para realizar a perda de peso em um paciente obeso, e, uso de um composto | |
DE60129550D1 (de) | Verwendung von niedrigen dosen estrogen in kombination mit immunotherapeutischen verbindungen zur behandlung von immunkrankheiten | |
LU92642I2 (fr) | Pomalidomide et ses sels, solvates, hydrates ou stéréoisomères pharmaceutiquement acceptables qui endérivent (Imnovid) | |
AR043188A1 (es) | Metodos y composiciones para el tratamiento de enfermedades y trastornos asociados con niveles elevados de citoquinas proinflamatorias | |
MXPA02008770A (es) | Compuestos azaciclicos para uso en el tratamiento de enfermedades relacionadas con la serotonina. | |
EA201000603A1 (ru) | ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ | |
TW200500355A (en) | Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases | |
BR0308928A (pt) | Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular | |
BR0309032A (pt) | Método para tratar sintomas vasomotores, a menopausa, deficiências hormonais em um paciente, e para tratar um paciente que sofre de sintomas vasomotores | |
EP1202725A4 (en) | METHOD FOR TREATING THE SYMPTOMS OF HORMONAL CHANGES, INCLUDING HOT WASHES | |
BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
EE200300031A (et) | Klimakteersete häirete ravimeetod naistel menopausi ajal või järel | |
HK1086479A1 (en) | The use of a ursodeoxycholic acid in the preparation of a medicament for treating a hemorrhage-associated nervous system injury | |
CO5190664A1 (es) | Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2 | |
BR0311146A (pt) | Uso de tibolona e de modulador de receptor de estrogênio seletivo, e, método e kit para o tratamento de um sintoma relacionado com a deficiência de estrogênio em um paciente do sexo feminino | |
MXPA05010871A (es) | Metodos para administrar estrogenos y progestinas. | |
DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
BR0314180A (pt) | Aminoéteres substituìdos para o tratamento da doença de alzheimer | |
DK0986393T3 (da) | Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer | |
EA199800864A1 (ru) | Способ лечения при боли, вызванной мигренью | |
BR0311613A (pt) | Métodos para inibição, tratamento ou prevenção de sintomas de atrofia da pele, ou atrofia epitelial ou da mucosa nas mulheres e utilização de composto | |
SI1596879T1 (sl) | Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice | |
WO2003032961A3 (en) | Methods for preventing and treating bone loss with steroid compounds | |
BRPI0410657A (pt) | composto, composição farmacêutica, uso de um composto, método para tratar um distúrbio de um paciente, e, processo para a preparação de um composto | |
BR0111900A (pt) | Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA:INT.CI. A61K 31/56, A61P 5/00 Ipc: A61K 31/56 (2011.01), A61P 5/00 (2011.01) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07F | Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette] |
Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2291 DE 02/12/2014. |